Clinical Trial Liaison, Clinical Development Operations MacroGenics, Inc.
Managed a global portfolio of more than 60 partner sites across eight countries, including academic cancer centers, for four early-stage oncology development programs. Served as the primary relationship owner for principal investigators and key opinion leaders from site selection and startup through ongoing performance.
Led site activation and acceleration planning that contributed to a 35% improvement in screening-to-enrollment conversion. Coordinated with CRO partners ICON and Fortrea to resolve site performance, compliance, and timeline risks; monitored quality issues, supported CAPA and root-cause reviews, and provided field intelligence to senior development leadership.
Presented program requirements at site launch meetings, investigator meetings, and international congresses. Designed and delivered training for more than 20 cross-functional colleagues on scientific mechanisms, study design, and clinical endpoints.